Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Year Presented Mixed Bag For India’s Pharmaceutical Industry

This article was originally published in PharmAsia News

Executive Summary

The 2008 year about to end was a mixed bag for India's pharmaceutical industry, beginning with good news the excise duty on pharma products would be cut in half. Of greatest interest during the year was Ranbaxy Laboratories, which began the year attempting to obtain Orchid Pharmaceuticals and ended the year being acquired itself. Sun Pharmaceuticals was not as lucky, failing in its attempt to take over Israel's Taro Pharmaceuticals and failing again when it attempted to force the acquisition in court by the end of the year. The issue is still pending. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067499

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel